Moreover, GHRH-arginine might not be the optimal test for diagnosing GHD in PWS as GHRH stimulates both pituitary GH synthesis and release [11, 12], whereas arginine potentiates the stimulatory effects of GHRH by inhibiting hypothalamic somatostatin release [13]. This evidence concerns the gene GH1 and Prader-Willi syndrome.